Cargando…

Ferroptosis-Related Gene Contributes to Immunity, Stemness and Predicts Prognosis in Glioblastoma Multiforme

Ferroptosis, a recently discovered regulated programmed cell death, is associated with tumorigenesis and progression in glioblastoma. Based on widely recognized ferroptosis-related genes (FRGs), the regulation of ferroptosis patterns and corresponding characteristics of immune infiltration of 516 GB...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dong, Jiawei, Zhao, Hongtao, Wang, Fang, Jin, Jiaqi, Ji, Hang, Yan, Xiuwei, Wang, Nan, Zhang, Jiheng, Hu, Shaoshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8960280/ https://www.ncbi.nlm.nih.gov/pubmed/35359663 http://dx.doi.org/10.3389/fneur.2022.829926

Ejemplares similares

Characterization of the Ferroptosis-Related Genes for Prognosis and Immune Infiltration in Low-Grade Glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Novel Immune-Related Gene-Based Signature Characterizing an Inflamed Microenvironment Predicts Prognosis and Radiotherapy Efficacy in Glioblastoma
por: Ji, Hang, et al.
Publicado: (2022)

Stromal protein CCN family contributes to the poor prognosis in lower-grade gioma by modulating immunity, matrix, stemness, and metabolism
por: Liu, Zhihui, et al.
Publicado: (2022)

Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma
por: Ma, Shuai, et al.
Publicado: (2022)

Expression of intra-tumoral necrosis-associated cytokine pattern correlated with prognosis and immune status in glioma
por: Zhao, Hongtao, et al.
Publicado: (2023)

Rapid progression of subcutaneous glioblastoma: A case report and literature review
por: Wang, Fang, et al.
Publicado: (2023)

IGFBPs were associated with stemness, inflammation, extracellular matrix remodeling and poor prognosis of low-grade glioma
por: Liu, Zhihui, et al.
Publicado: (2022)

5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas
por: Zhang, Jiheng, et al.
Publicado: (2022)

Integrated genomic, transcriptomic, and epigenetic analyses identify a leukotriene synthesis-related M2 macrophage gene signature that predicts prognosis and treatment vulnerability in gliomas
por: Ji, Hang, et al.
Publicado: (2022)

A cuproptosis-related lncRNAs signature for prognosis, chemotherapy, and immune checkpoint blockade therapy of low-grade glioma
por: Yan, Xiuwei, et al.
Publicado: (2022)

Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas
por: Dong, Jiawei, et al.
Publicado: (2023)

Emerging Cellular Therapies for Glioblastoma Multiforme
por: Choi, Paul J, et al.
Publicado: (2018)

Machine learning-based screening of an epithelial-mesenchymal transition-related long non-coding RNA signature reveals lower-grade glioma prognosis and the tumor microenvironment and predicts antitumor therapy response
por: Wang, Nan, et al.
Publicado: (2022)

Bidirectional Relation Between Parkinson's Disease and Glioblastoma Multiforme
por: Mencke, Pauline, et al.
Publicado: (2020)

Using mixed reality technique combines multimodal imaging signatures to adjuvant glioma photodynamic therapy
por: Dong, Jiawei, et al.
Publicado: (2023)

Bone Metastasis From Glioblastoma Multiforme: A Case Report
por: Zapata Laguado, Martin, et al.
Publicado: (2022)

Socioeconomic status does not affect prognosis in patients with glioblastoma multiforme
por: Kasl, Rebecca A., et al.
Publicado: (2016)

Glioblastoma Multiforme Survivor With Radiation-Induced Consequences: A Case Report
por: Hunt, Christina M, et al.
Publicado: (2022)

The Survival Benefit of Postoperative Bacterial Infections in Patients With Glioblastoma Multiforme: Myth or Reality?
por: Kazim, Syed Faraz, et al.
Publicado: (2021)

Potential Molecular Mechanism of TNF Superfamily-Related Genes in Glioblastoma Multiforme Based on Transcriptome and Epigenome
por: Xie, Hui, et al.
Publicado: (2021)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Machine Learning Analytics of Resting-State Functional Connectivity Predicts Survival Outcomes of Glioblastoma Multiforme Patients
por: Lamichhane, Bidhan, et al.
Publicado: (2021)

Expression of MECOM is associated with unfavorable prognosis in glioblastoma multiforme
por: Hou, Aiwu, et al.
Publicado: (2016)

Glioblastoma multiforme: Diagnosis, treatment, and invasion
por: Li, Jiawei, et al.
Publicado: (2023)

Neutrophil extracellular traps contribute to coagulopathy after traumatic brain injury
por: Jin, Jiaqi, et al.
Publicado: (2023)

Cancer Stem Cells in Glioblastoma Multiforme
por: Bradshaw, Amy, et al.
Publicado: (2016)

M6A RNA Methylation Regulator HNRNPC Contributes to Tumorigenesis and Predicts Prognosis in Glioblastoma Multiforme
por: Wang, Li-chong, et al.
Publicado: (2020)

Modulation of Tumor Immune Microenvironment and Prognostic Value of Ferroptosis-Related Genes, and Candidate Target Drugs in Glioblastoma Multiforme
por: Zhang, Xudong, et al.
Publicado: (2022)

Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme
por: Yu, Ziye, et al.
Publicado: (2022)

Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model
por: Goodarzi, Arash, et al.
Publicado: (2020)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

Cancer Stem Cell Hierarchy in Glioblastoma Multiforme
por: Bradshaw, Amy, et al.
Publicado: (2016)

Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas
por: Wu, Jiasheng, et al.
Publicado: (2022)

Establishment and Validation of a Ferroptosis-Related lncRNA Signature for Prognosis Prediction in Lower-Grade Glioma
por: Huang, Qian-Rong, et al.
Publicado: (2022)

TGF-β based risk model to predict the prognosis and immune features in glioblastoma
por: Liu, Hongchao, et al.
Publicado: (2023)

Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices
por: Du, Jianyang, et al.
Publicado: (2020)

Construction of Interferon-Gamma-Related Gene Signature to Characterize the Immune-Inflamed Phenotype of Glioblastoma and Predict Prognosis, Efficacy of Immunotherapy and Radiotherapy
por: Ji, Hang, et al.
Publicado: (2021)

Genomic Analysis of Glioblastoma Multiforme Reveals a Key Transcription Factor Signature Relevant to Prognosis and the Immune Processes
por: Li, Zhen-Hang, et al.
Publicado: (2021)

Morphometic analysis of TCGA glioblastoma multiforme
por: Chang, Hang, et al.
Publicado: (2011)

Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme
por: Miska, Jason, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a69ai2ignfeamkggl86dpehr29